DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C2239176 | Liver carcinoma | UGP2 | 7360 | UDP-glucose pyrophosphorylase 2 | Q16851 |
C0017638 | Glioma | UGP2 | 7360 | UDP-glucose pyrophosphorylase 2 | Q16851 |
C0016952 | Galactosemias | UGP2 | 7360 | UDP-glucose pyrophosphorylase 2 | Q16851 |
C0017636 | Glioblastoma | UGP2 | 7360 | UDP-glucose pyrophosphorylase 2 | Q16851 |
C0235974 | Pancreatic carcinoma | UGP2 | 7360 | UDP-glucose pyrophosphorylase 2 | Q16851 |
C0345904 | Malignant neoplasm of liver | UGP2 | 7360 | UDP-glucose pyrophosphorylase 2 | Q16851 |
C0006826 | Malignant Neoplasms | UGGT2 | 55757 | UDP-glucose glycoprotein glucosyltransferase 2 | Q9NYU1 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | UGGT2 | 55757 | UDP-glucose glycoprotein glucosyltransferase 2 | Q9NYU1 |
C1306459 | Primary malignant neoplasm | UGGT2 | 55757 | UDP-glucose glycoprotein glucosyltransferase 2 | Q9NYU1 |
C0027051 | Myocardial Infarction | UGGT2 | 55757 | UDP-glucose glycoprotein glucosyltransferase 2 | Q9NYU1 |
C0006826 | Malignant Neoplasms | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0019196 | Hepatitis C | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0600139 | Prostate carcinoma | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0947622 | Cholecystolithiasis | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0221757 | alpha 1-Antitrypsin Deficiency | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0036572 | Seizures | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0017551 | Gilbert Disease (disorder) | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0002895 | Anemia, Sickle Cell | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0271979 | Thalassemia Intermedia | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0008350 | Cholelithiasis | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0023895 | Liver diseases | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0857007 | Hyperbilirubinemia, Neonatal | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0010324 | Crigler Najjar syndrome, type 1 | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0020433 | Hyperbilirubinemia | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0027947 | Neutropenia | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024